Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Metcalfe

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
The New Zealand Medical Journal|December 24, 2005
PHARMAC responds on TNF inhibitors for inflammatory arthritisScott Metcalfe, Peter Moodie, Rachel Grocott, et al.
The New Zealand Medical Journal|December 3, 2014
Self-monitoring blood glucose test strip use with diabetes medicines in people with types 1 and 2 diabetes in New ZealandScott Metcalfe, Peter Moodie, Hew Norris, et al.
The New Zealand Medical Journal|March 27, 2003
PHARMAC measures savings elsewhere to the health sectorScott Metcalfe, Sean Dougherty, Matthew Brougham, et al.
The New Zealand Medical Journal|October 27, 2017
Time for healthy investmentScott Metcalfe, Sanji Gunasekara, Kate Baddock, et al.
The New Zealand Medical Journal|August 2, 2005
PHARMAC responds to Richard Milne on discounting health benefits and costsScott Metcalfe, Matthew Brougham, Peter Moodie, et al.
The New Zealand Medical Journal|September 1, 2005
PHARMAC responds to Stewart Mann on dihydropyridine calcium channel antagonistsAndrew Davies, Scott Metcalfe, Peter Moodie, et al.
Lancet (London, England)|February 14, 2003
Heart Protection StudyR Scott Metcalfe, Sandy Dawson, Richard J Milne
Seminars in Oncology|October 22, 2018
Response to Cameron et al "Mind the graph" Semin Oncol. 2018George Laking, Jackie Evans, Scott Metcalfe, et al.
The New Zealand Medical Journal|September 3, 2005
PHARMAC responds on salbutamolScott Metcalfe, Peter Moodie, Andrew Davies, et al.
The New Zealand Medical Journal|November 3, 2016
Combating antimicrobial resistance demands nation-wide action and global governanceScott Metcalfe, Michael G Baker, Joshua Freeman, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
The New Zealand Medical Journal|December 24, 2005
PHARMAC responds on TNF inhibitors for inflammatory arthritisScott Metcalfe, Peter Moodie, Rachel Grocott, et al.
The New Zealand Medical Journal|December 3, 2014
Self-monitoring blood glucose test strip use with diabetes medicines in people with types 1 and 2 diabetes in New ZealandScott Metcalfe, Peter Moodie, Hew Norris, et al.
The New Zealand Medical Journal|March 27, 2003
PHARMAC measures savings elsewhere to the health sectorScott Metcalfe, Sean Dougherty, Matthew Brougham, et al.
The New Zealand Medical Journal|October 27, 2017
Time for healthy investmentScott Metcalfe, Sanji Gunasekara, Kate Baddock, et al.
The New Zealand Medical Journal|August 2, 2005
PHARMAC responds to Richard Milne on discounting health benefits and costsScott Metcalfe, Matthew Brougham, Peter Moodie, et al.
The New Zealand Medical Journal|September 1, 2005
PHARMAC responds to Stewart Mann on dihydropyridine calcium channel antagonistsAndrew Davies, Scott Metcalfe, Peter Moodie, et al.
Lancet (London, England)|February 14, 2003
Heart Protection StudyR Scott Metcalfe, Sandy Dawson, Richard J Milne
Seminars in Oncology|October 22, 2018
Response to Cameron et al "Mind the graph" Semin Oncol. 2018George Laking, Jackie Evans, Scott Metcalfe, et al.
The New Zealand Medical Journal|September 3, 2005
PHARMAC responds on salbutamolScott Metcalfe, Peter Moodie, Andrew Davies, et al.
The New Zealand Medical Journal|November 3, 2016
Combating antimicrobial resistance demands nation-wide action and global governanceScott Metcalfe, Michael G Baker, Joshua Freeman, et al.
Pageof 7